Pharmacist Moms Group^™

Jeffery A. Goad, PharmD, MPH, explains how recent HHS policy changes reorganizing the childhood immunization schedule could complicate routine vaccination practices and increase the risk of gaps in pediatric disease prevention.

Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, highlights the EPCORE FL-1 trial, which showed that adding epcoritamab to rituximab and lenalidomide improved response rates and reduced progression risk in patients with relapsed or refractory follicular lymphoma.

Pharmacists enhance community health through outreach programs, offering vaccinations, health screenings, and education to improve access and trust in health care.

This final segment consists of expert clinicians offering key takeaways to help pharmacists prepare for potential approvals and integrate new TNBC therapies into practice.

In this episode, the panel explains how structured assessments such as the Abnormal Involuntary Movement Scale are essential tools for identifying tardive dyskinesia and distinguishing it from other drug induced movement disorders.

Explore the latest advancements in bleeding disorder treatments, including factor replacement therapies and innovative rebalancing agents for improved patient care.

In this episode, the panel focuses on how enhancing patient and clinician education can improve early recognition of tardive dyskinesia.

This segment summarizes early DB-1305 data showing promising efficacy and manageable toxicity in pretreated TNBC, along with ongoing investigation of combination strategies such as anti-PD-L1 × VEGF bispecific therapy.

Explore the profound impact of hemophilia on patients' lives and the health care system, highlighting the essential role of pharmacists in care management.